COVID-19 Information Center

Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.

Resources:

Frequently Asked
Questions Novartis COVID-19
Information Center

Recent News:

Novartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19
July 16, 2020

Sandoz responds to increased demand for antibiotics and other essential medicines for patients during COVID-19
May 19, 2020

Educational program to share knowledge and best practice on Covid-19 among HCPs globally
May 12, 2020

Novartis to sponsor large clinical trial of hydroxychloroquine in hospitalized COVID-19 patients
Apr 20, 2020

Novartis donation: Consignment of 30 million hydroxychloroquine tablets ships to US Department of Health and Human Services
Mar 30, 2020

Novartis commits to donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic response
Mar 20, 2020

Sandoz commits to keep prices stable for basket of essential COVID-19 medicines; Novartis responds to COVID-19 with broad range of initiatives
Feb 26, 2020

Leadership Perspectives:

Richard Saynor: Playing our part to overcome the COVID-19 pandemic
Mar 20, 2020

Richard Saynor: Coronavirus and the generics industry supply chain
Feb 26, 2020